IL-2, IL-6 and chitinase 3-like 2 might predict early relapse activity in multiple sclerosis

por Petržalka, Marko, Meluzínová, Eva, Libertínová, Jana, Mojžišová, Hana, Hanzalová, Jitka, Ročková, Petra, Elišák, Martin, Kmetonyová, Silvia, Šanda, Jan, Sobek, Ondřej, Marusič, Petr
Publicado 2022

Antibodies Contributing to Focal Epilepsy Signs and Symptoms Score

por de Bruijn, Marienke A. A. M., Bastiaansen, Anna E. M., Mojzisova, Hana, van Sonderen, Agnes, Thijs, Roland D., Majoie, Marian J. M., Rouhl, Rob P. W., van Coevorden‐Hameete, Marleen H., de Vries, Juna M., Muñoz Lopetegi, Amaia, Roozenbeek, Bob, Schreurs, Marco W. J., Sillevis Smitt, Peter A. E., Titulaer, Maarten J.
Publicado 2021

Genome-wide Association Study Identifies 2 New Loci Associated With Anti-NMDAR Encephalitis

por Tietz, Anja K., Angstwurm, Klemens, Baumgartner, Tobias, Doppler, Kathrin, Eisenhut, Katharina, Elisak, Martin, Franke, Andre, Golombeck, Kristin S., Handreka, Robert, Kaufmann, Max, Kraemer, Markus, Kraft, Andrea, Lewerenz, Jan, Lieb, Wolfgang, Madlener, Marie, Melzer, Nico, Mojzisova, Hana, Möller, Peter, Pfefferkorn, Thomas, Prüss, Harald, Rostásy, Kevin, Schnegelsberg, Margret, Schröder, Ina, Siebenbrodt, Kai, Sühs, Kurt-Wolfram, Wickel, Jonathan, Wandinger, Klaus-Peter, Leypoldt, Frank, Kuhlenbäumer, Gregor
Publicado 2021